New stock news | Zhiyuan Pharmaceutical filed an application with the Hong Kong Stock Exchange.

According to the Zhixun Finance APP, it was disclosed by the Hong Kong Stock Exchange on July 9th that Jiangsu Zhijin Pharmaceutical Co., Ltd. (referred to as Zhijin Pharmaceutical) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with CITIC Securities as its exclusive sponsor. According to the prospectus, the company is a Chinese pharmaceutical company focusing on the field of dermatology, with leading products in multiple treatment areas, providing a comprehensive "head-to-toe" solution covering skin medications and medical-grade skincare products.